Microstructured Skin-Interface Platform
Physical, structural, and localized architecture developed on a synthetic, defined, and traceable material platform.
A Clear Product Identity
What is APHELAR™?
APHELAR™ is a passive, synthetic, single-use microstructured skin-interface device. It integrates a hydrophilic structural matrix and a defined phospholipid-peptide material architecture within a controlled microstructured configuration.
Microstructure
Defined and reproducible physical geometry.
Material architecture
Controlled integration of matrix, lipid families, and structural peptide motifs.
Localized interface
Interaction concentrated at the application site.
Physical transition
Hydration and controlled material evolution during use.
Traceability
Identity, formulation, lot, and documentation connected through STIP™.
Intended Purpose
Minimal-Intervention Microstructure
Fine microprojections for localized skin engagement
APHELAR™ uses a surface of solid, extremely fine, low-profile microprojections integrated into an almost transparent matrix. The geometry is designed to establish brief, controlled, localized skin engagement using only the dimensions required to create a reproducible physical interface.
Geometric height is a device design and manufacturing parameter and is not used as an equivalent of tissue-interaction depth. The configuration prioritizes the minimum physical intervention compatible with its interface function.
[Microstructure Geometry Interface]
Material Architecture
A defined multi-component platform
APHELAR™ is not defined by a single ingredient. Its identity derives from the organized integration of different material families forming one unified architecture.
A synthetic and defined architecture
APHELAR™ is built as a material platform independent of complex cellular sources. Its material identity is based on specified raw materials, controlled architecture, reproducible manufacturing, identified finished product, and lot traceability.
Membrane and microdomain science
Biological membranes exhibit complex levels of spatial organization. Phospholipids, sphingolipids, sterols, and proteins can organize within dynamic regions known as microdomains.
Published Scientific Foundation
Peer-reviewed scientific lineage supporting the platform
APHELAR™ is developed within a peer-reviewed scientific program that has progressively examined phospholipoproteic architectures, membrane and microdomain organization, molecular stability, analytical reproducibility, ex vivo compatibility, and structured traceability.
| No. | Scientific Publication | Scientific Contribution |
|---|---|---|
| 1 | Cancers. 2025;17(10):1658. doi:10.3390/cancers17101658 | Phospholipoproteic platform architecture, purification, molecular characterization, and scalability. |
| 2 | Biomedicines. 2025;13(6):1299. doi:10.3390/biomedicines13061299 | Phospholipid-rich architecture, preserved molecular fingerprints, structural stability, and reproducibility. |
| 3 | Int. J. Mol. Sci. 2025;26(12):5444. doi:10.3390/ijms26125444 | Multistage monitoring framework, molecular quality control, immune profiling, and STIP™ architecture. |
| 4 | Biology. 2025;14(8):953. doi:10.3390/biology14080953 | Real-time, label-free, non-cytotoxic functional stratification and reproducible ex vivo monitoring. |
| 5 | Biomedicines. 2025;13(9):2101. doi:10.3390/biomedicines13092101 | Ex vivo traceability, batch comparability, kinetic documentation, and evidence architecture without clinical exposure. |
| 6 | Int. J. Mol. Sci. 2026;27:2305. doi:10.3390/ijms27052305 | Integrative mechanistic synthesis of membrane organization, microdomains, spatial signaling, and structural interfaces. |
| 7 | Pharmaceutics. 2026;18:847. doi:10.3390/pharmaceutics18070847 | Proteomic stability, analytical reproducibility, processing robustness, and short-term ex vivo cellular compatibility. |
Technical-Regulatory Profile
A clearly defined technical configuration
The product technical identity remains constant and can be recognized within frameworks that provide proportionate administrative pathways.
Production & Control Architecture
Safety by Design
The APHELAR™ control architecture focuses on parameters inherent to a physical interface device: materials (identity and purity), geometry (microstructured configuration), biocompatibility, microbiology, stability, packaging, manufacturing, and traceability.
Controlled Manufacturing
From raw material to finished unit. APHELAR™ maintains a reproducible and fully reconstructible manufacturing chain.
STIP™ Traceability
STIP™ is the cross-functional documentation layer of APHELAR™ and maintains continuity across product, configuration, formulation, raw materials, lot, fingerprint, release, and documentation.
Documentary Consistency
A single technical identity across all carriers
APHELAR™ maintains the same functional identity across product definition, intended purpose, composition, labeling, instructions for use, public information, technical documentation, and traceability.
